Compare TPB & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPB | STAA |
|---|---|---|
| Founded | 1988 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Tobacco | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2015 | 1995 |
| Metric | TPB | STAA |
|---|---|---|
| Price | $60.48 | $22.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $115.00 | $22.81 |
| AVG Volume (30 Days) | 318.6K | ★ 837.2K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | ★ 45.33 | N/A |
| EPS | ★ 3.11 | 0.26 |
| Revenue | ★ $463,062,000.00 | $239,442,000.00 |
| Revenue This Year | $13.68 | $30.82 |
| Revenue Next Year | $11.32 | $8.41 |
| P/E Ratio | ★ $19.51 | $86.81 |
| Revenue Growth | ★ 28.39 | N/A |
| 52 Week Low | $58.57 | $15.59 |
| 52 Week High | $146.90 | $35.87 |
| Indicator | TPB | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 25.58 | 52.36 |
| Support Level | N/A | $21.72 |
| Resistance Level | $91.03 | $24.31 |
| Average True Range (ATR) | 2.69 | 0.99 |
| MACD | -0.62 | 0.05 |
| Stochastic Oscillator | 13.19 | 74.42 |
Turning Point Brands Inc operates as a manufacturer, marketer, and provider of consumer products that include Other Tobacco Products (OTP) in the U.S. The company offers a wide variety across the OTP spectrum, including moist snuff tobacco (MST), loose-leaf chewing tobacco, premium cigarette papers, make- your-own (MYO) cigar wraps, cigars, liquid vapor products, and tobacco vaporizer products. It operates in two segments, namely Zig-Zag products and Stoker's products segment. The company generates maximum revenue from the Zig-Zag products segment.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.